SG11201701529YA - Antibody therapeutics that bind oprf and oprl - Google Patents
Antibody therapeutics that bind oprf and oprlInfo
- Publication number
- SG11201701529YA SG11201701529YA SG11201701529YA SG11201701529YA SG11201701529YA SG 11201701529Y A SG11201701529Y A SG 11201701529YA SG 11201701529Y A SG11201701529Y A SG 11201701529YA SG 11201701529Y A SG11201701529Y A SG 11201701529YA SG 11201701529Y A SG11201701529Y A SG 11201701529YA
- Authority
- SG
- Singapore
- Prior art keywords
- oprl
- antibody therapeutics
- oprf
- bind
- bind oprf
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1214—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462044107P | 2014-08-29 | 2014-08-29 | |
| PCT/US2015/047576 WO2016033547A1 (en) | 2014-08-29 | 2015-08-28 | Antibody therapeutics that bind oprf and oprl |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201701529YA true SG11201701529YA (en) | 2017-03-30 |
Family
ID=55400714
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201701529YA SG11201701529YA (en) | 2014-08-29 | 2015-08-28 | Antibody therapeutics that bind oprf and oprl |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9879069B2 (en) |
| EP (1) | EP3185897A4 (en) |
| JP (1) | JP2017526686A (en) |
| KR (1) | KR20170068456A (en) |
| CN (1) | CN107073096A (en) |
| AU (1) | AU2015308625A1 (en) |
| BR (1) | BR112017003983A2 (en) |
| CA (1) | CA2959165A1 (en) |
| EA (1) | EA201790489A1 (en) |
| IL (1) | IL250755A0 (en) |
| MA (1) | MA40528A (en) |
| MX (1) | MX2017002674A (en) |
| PH (1) | PH12017500368A1 (en) |
| SG (1) | SG11201701529YA (en) |
| WO (1) | WO2016033547A1 (en) |
| ZA (1) | ZA201701915B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114874322A (en) | 2016-03-10 | 2022-08-09 | 维埃拉生物股份有限公司 | ILT7 binding molecules and methods of use thereof |
| WO2017163049A1 (en) * | 2016-03-21 | 2017-09-28 | Kymab Limited | Anti-malarial antibodies that bind circumsporozoite protein |
| US11066464B2 (en) | 2016-03-21 | 2021-07-20 | Kymab Limited | Anti-malarial antibodies that bind circumsporozoite protein |
| JP7179719B2 (en) * | 2016-06-06 | 2022-11-29 | ポリセリックス・リミテッド | Antibodies, uses thereof and conjugates thereof |
| WO2019178356A1 (en) * | 2018-03-14 | 2019-09-19 | Dana-Farber Cancer Institute, Inc. | Engineered cells, t cell immune modulating antibodies and methods for using the same |
| JP7104458B2 (en) * | 2018-04-02 | 2022-07-21 | 上海博威生物医薬有限公司 | Lymphocyte activation gene-3 (LAG-3) -binding antibody and its use |
| FR3099160B1 (en) * | 2019-07-23 | 2022-05-06 | Univ Grenoble Alpes | ANTIBODIES DIRECTED AGAINST THE PROTEIN OPRF DEPSEUDOMONAS AERUGINOSA, ITS USE AS A MEDICINE AND PHARMACEUTICAL COMPOSITION CONTAINING IT |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69515613T2 (en) * | 1994-12-16 | 2000-11-30 | Chiron Behring Gmbh & Co. | Immunogenic hybrid protein OprF-Oprl available from membrane proteins from Pseudomonas aeruginosa |
| US9403904B2 (en) * | 2008-11-07 | 2016-08-02 | Fabrus, Inc. | Anti-DLL4 antibodies and uses thereof |
| JP5893640B2 (en) * | 2010-12-23 | 2016-03-23 | ファルネファ オーストリア ゲーエムベーハー | OPRF / I reagent and its use in hospitalization and other patients |
| EP2678369B1 (en) * | 2011-02-23 | 2015-05-06 | AlzChem AG | High-latency hardeners for epoxy resins |
| CA2872030A1 (en) | 2012-05-31 | 2013-12-05 | Sorrento Therapeutics, Inc. | Antigen binding proteins that bind pd-l1 |
-
2015
- 2015-08-28 CA CA2959165A patent/CA2959165A1/en not_active Abandoned
- 2015-08-28 JP JP2017511769A patent/JP2017526686A/en active Pending
- 2015-08-28 CN CN201580058763.4A patent/CN107073096A/en active Pending
- 2015-08-28 WO PCT/US2015/047576 patent/WO2016033547A1/en active Application Filing
- 2015-08-28 US US14/839,791 patent/US9879069B2/en active Active
- 2015-08-28 MA MA040528A patent/MA40528A/en unknown
- 2015-08-28 SG SG11201701529YA patent/SG11201701529YA/en unknown
- 2015-08-28 AU AU2015308625A patent/AU2015308625A1/en not_active Abandoned
- 2015-08-28 BR BR112017003983A patent/BR112017003983A2/en not_active Application Discontinuation
- 2015-08-28 EP EP15836510.6A patent/EP3185897A4/en not_active Withdrawn
- 2015-08-28 MX MX2017002674A patent/MX2017002674A/en unknown
- 2015-08-28 KR KR1020177008688A patent/KR20170068456A/en unknown
- 2015-08-28 EA EA201790489A patent/EA201790489A1/en unknown
-
2017
- 2017-02-23 IL IL250755A patent/IL250755A0/en unknown
- 2017-02-28 PH PH12017500368A patent/PH12017500368A1/en unknown
- 2017-03-17 ZA ZA2017/01915A patent/ZA201701915B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PH12017500368A1 (en) | 2017-07-10 |
| KR20170068456A (en) | 2017-06-19 |
| MA40528A (en) | 2017-07-05 |
| CA2959165A1 (en) | 2016-03-03 |
| WO2016033547A1 (en) | 2016-03-03 |
| EP3185897A1 (en) | 2017-07-05 |
| WO2016033547A8 (en) | 2017-04-06 |
| EA201790489A1 (en) | 2017-08-31 |
| IL250755A0 (en) | 2017-04-30 |
| EP3185897A4 (en) | 2018-05-02 |
| AU2015308625A1 (en) | 2017-04-20 |
| MX2017002674A (en) | 2017-09-19 |
| BR112017003983A2 (en) | 2018-02-14 |
| JP2017526686A (en) | 2017-09-14 |
| CN107073096A (en) | 2017-08-18 |
| ZA201701915B (en) | 2018-05-30 |
| US20160060326A1 (en) | 2016-03-03 |
| US9879069B2 (en) | 2018-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL287958A (en) | Antibody therapeutics that bind cd47 | |
| IL284336B (en) | Antibody therapeutics that bind ctla4 | |
| HK1253584A1 (en) | Antibody therapeutics that bind cd38 | |
| IL254260A0 (en) | Antibody therapeutics that bind tim3 | |
| IL254088A0 (en) | Antibody therapeutics that bind cd137 | |
| IL252004A0 (en) | Domain-exchanged antibody | |
| EP3325009A4 (en) | Antibody therapeutics that bind lag3 | |
| GB201411320D0 (en) | Antibody construct | |
| IL284291A (en) | Humanized anti-acth antibodies and use thereof | |
| PT3166970T (en) | Improved aãy protofibril binding antibodies | |
| SG11201701529YA (en) | Antibody therapeutics that bind oprf and oprl | |
| IL291164A (en) | Anti-nme antibody | |
| EP3280442A4 (en) | Antibody therapeutics that bind cd123 | |
| IL254310A0 (en) | Antibody therapeutics that bind psma | |
| IL251676A0 (en) | Antibodies that bind to ccr6 and their uses | |
| GB201410520D0 (en) | Antibody | |
| EP3157634A4 (en) | Antibodies that bind lgr4 | |
| EP3131580A4 (en) | Antibody therapeutics that bind cd147 | |
| SG11201700922YA (en) | Anti-orai1 antibody | |
| IL254356A0 (en) | Antibody therapeutics that bind jag1 | |
| GB201418776D0 (en) | Antibody | |
| GB201413745D0 (en) | Antibody | |
| GB201411319D0 (en) | Antibody | |
| GB201407535D0 (en) | Antibody Drug - Conjugates | |
| GB201418781D0 (en) | Antibody epitope |